Fatigue and Sleep in Patients With COVID-19
COFATSOM
1 other identifier
observational
60
1 country
1
Brief Summary
Recent studies show that patients who have contracted COVID-19 retain very significant fatigue after resolving the infectious episode. This fatigue may be explained by low-grade inflammation. There is more data for patients with COVID-19 who have been hospitalized than for non-hospitalized patients with milder forms. However, COVID-19 related fatigue would not only affect elderly people with severe cardiopulmonary consequences but also young subjects without severities. This notion is not very widespread and to date, COVID contracted by young subjects is considered to have very few consequences on their health. It is also known that the prevalence of sleep debt is significant in the general population and particularly in young people, and it is also known that sleep deprivation increases low-grade inflammation and facilitates the risk of viral contamination. The association between sleep deprivation, drowsiness and possibly low-grade inflammation raise questions about the mechanisms of fatigue in the general population. Investigators are also entitled to wonder to what extent the chronic sleep debt suffered by the French population can explain an increased risk of contamination by COVID 19 but also significant residual fatigue after COVID infection. Bordeaux University Hospital screens 2,000 subjects per day at risk of being infected by COVID, it would be very interesting to measure, in a population of young adults aged 18-45 years, frequently exposed to a sleep debt, sleep hygiene (bedtime and wake-up times, sleep and wake-up schedules, and overall sleep satisfaction), average sleep duration, level of fatigue and drowsiness and to compare these thresholds between subjects with or without COVID 19 according to nasopharyngeal PCR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2020
CompletedFirst Posted
Study publicly available on registry
December 8, 2020
CompletedStudy Start
First participant enrolled
March 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 13, 2021
CompletedJune 16, 2021
June 1, 2021
3 months
December 7, 2020
June 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fatigue Severity Scale
Presence of significant fatigue as measured by the Fatigue Severity Scale (FSS) at 1 month. Score from 1 to 7 FSS is a 9-item questionnaire with questions related to how fatigue interferes with certain activities and rates its severity according to a self-report scale. The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree. The minimum score is 9 and maximum score possible is 63. Higher is the score, greater is the fatigue severity
one month after inclusion (T0)
Secondary Outcomes (3)
COVID Diagnosis
inclusion (T0)
Fatigue evolution
Inclusion (T0) and one month after
Sleep hygiene
Inclusion (T0) and one month after
Study Arms (1)
Participant
Patient or health professional coming to the Bordeaux University Hospital screening center for COVID-19 screening
Interventions
Self-questionnaires will be completed by the participants : * General health and mental health * Fatigue * Burn-Out * Sleepiness * Sleep hygiene * Symptoms of COVID
Eligibility Criteria
Patient or healthcare professional going to screening center to perform a PCR test for COVID-19
You may qualify if:
- Patient or healthcare professional going to screening center to perform a PCR test for COVID-19
- Between 18 and 45 years old
- Symptomatic or not
- Whether or not COVID-19 contact-case
- Accepting to participate to the research
- Informed and having expressly transmitted their non-opposition to participate in the study
You may not qualify if:
- Participants who do not speak French or who cannot read or write
- Patients who do not have contact information for recall
- Refusal to participate in the study.
- Majors under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux
Bordeaux, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2020
First Posted
December 8, 2020
Study Start
March 8, 2021
Primary Completion
June 13, 2021
Study Completion
June 13, 2021
Last Updated
June 16, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share